Amorphex Therapeutics is a clinical stage company developing patented technology to address the problems associated with topical ophthalmic drug delivery, a $5+billion dollar market that includes the primary treatment of glaucoma. Topical ophthalmic pharmaceuticals are typically self-administered…
Finance: Commercial Banking, Lending, Underwriting
No mentions listed yet.
No one has curated this page yet. Be the first.
Curate